NVO - AstraZeneca looking to ramp up in-house production amid Catalent deal
2024-02-09 13:21:35 ET
More on AstraZeneca
- AstraZeneca PLC (AZN) Q4 2023 Earnings Call Transcript
- AstraZeneca FY23 Earnings Review: It's OK To Buy Dip On Q4 Bottom Line Miss
- AstraZeneca PLC 2023 Q4 - Results - Earnings Call Presentation
- Ionis-AstraZeneca amyloid cardiomyopathy candidate gets FDA fast track designation
- AstraZeneca tumbles despite Q4 beat